Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Bell's palsy
ADR ID BADD_A09535
ADR Hierarchy
17      Nervous system disorders
17.04      Cranial nerve disorders (excl neoplasms)
17.04.03      Facial cranial nerve disorders
17.04.03.011      Bell's palsy
Description A syndrome characterized by the acute onset of unilateral FACIAL PARALYSIS which progresses over a 2-5 day period. Weakness of the orbicularis oculi muscle and resulting incomplete eye closure may be associated with corneal injury. Pain behind the ear often precedes the onset of paralysis. This condition may be associated with HERPESVIRUS 1, HUMAN infection of the facial nerve. (Adams et al., Principles of Neurology, 6th ed, p1376) [MeSH]
MedDRA Code 10004223
MeSH ID D020330
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Bell's palsy | Palsy Bells | Idiopathic acute peripheral facial nerve palsy | Bell Palsy | Bell Palsies | Palsies, Bell | Palsy, Bell | Facial Neuropathy, Inflammatory, Acute | Facial Paralysis, Idiopathic | Facial Paralyses, Idiopathic | Idiopathic Facial Paralyses | Idiopathic Facial Paralysis | Paralyses, Idiopathic Facial | Paralysis, Idiopathic Facial | Inflammatory Facial Neuropathy, Acute | Acute Inflammatory Facial Neuropathy | Facial Neuropathy, Idiopathic Acute | Idiopathic Acute Facial Neuropathy | Bell's Palsy | Bell's Palsies | Bells Palsy | Palsies, Bell's | Palsy, Bell's | Acute Idiopathic Facial Neuropathy | Herpetic Facial Paralysis | Facial Paralyses, Herpetic | Facial Paralysis, Herpetic | Herpetic Facial Paralyses | Paralyses, Herpetic Facial | Paralysis, Herpetic Facial
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00023Acetaminophen--
BADD_D00195Azathioprine--
BADD_D00981Gabapentin--
BADD_D01083Hydrochlorothiazide--
BADD_D01119Ibrutinib0.000112%
BADD_D01213Isotretinoin0.000257%
BADD_D01217Itraconazole--
BADD_D01253Lenalidomide0.000723%
BADD_D01281Levonorgestrel0.000473%
BADD_D01285Levothyroxine--
BADD_D01418Methotrexate--
BADD_D01442Metoclopramide0.000294%
BADD_D01449Metronidazole0.000053%
BADD_D01491Mometasone furoate--
BADD_D01533Naproxen--
BADD_D01567Nilotinib--
BADD_D01656Paliperidone0.001366%
BADD_D01834Prednisone--
BADD_D02236Tofacitinib--
BADD_D02337Varenicline--
BADD_D02375Water--
BADD_D02392Zoledronic acid--
BADD_D02412Octreotide0.000186%
BADD_D02436Atorvastatin--
BADD_D02464Fingolimod--
BADD_D02490Apalutamide0.000334%
The 1th Page    1    Total 1 Pages